Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study
在接受抗卡氏肺囊虫肺炎治疗后 2 周内开始抗逆转录病毒治疗，不会增加 HIV 相关中重度卡氏肺囊虫肺炎患者的死亡率或艾滋病相关事件发生率：一项前瞻性观察性多中心研究的结果
期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-022-02118-4
Zeng, Yan-Ming; Li, Yao; Lu, Yan-Qiu; Liu, Min; Nie, Jing-Min; Yuan, Jing; Harypursat, Vijay; Zhou, Yi-Hong; Qin, Yuan-Yuan; Chen, Xiao-Hong; Zhang, Yu-Lin; Zhang, De-Fa; Wang, Ni; Chen, Hui; Tian, Qun; Zhou, Yang; Qin, Ying-Mei; Yang, Xin-Ping; Chen, Yao-Kai
